Increased Diagnosis of Hepatocellular Carcinoma in Hospitalized Patients with Alcohol Related Hepatitis after the Covid-19 Outbreak: A Global Multi-Center Propensity Matched Analysis.
作者信息
Perisetti Abhilash, Kaur Randeep, Thandassery Ragesh
机构信息
Division of Gastroenterology, Department of Medicine, Central Arkansas Veteran Healthcare System, Division of Gastroenterology, Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
出版信息
Clin Gastroenterol Hepatol. 2021 Nov;19(11):2450-2451.e1. doi: 10.1016/j.cgh.2021.05.010. Epub 2021 May 11.
Abstract
摘要
相似文献
1
Increased Diagnosis of Hepatocellular Carcinoma in Hospitalized Patients with Alcohol Related Hepatitis after the Covid-19 Outbreak: A Global Multi-Center Propensity Matched Analysis.
Clin Gastroenterol Hepatol. 2021 Nov;19(11):2450-2451.e1. doi: 10.1016/j.cgh.2021.05.010. Epub 2021 May 11.
2
[Hepatocellular carcinoma and physicians of internal medicine (discussion)].
Nihon Naika Gakkai Zasshi. 1995 Dec 10;84(12):2043-55.
3
Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Alcohol Clin Exp Res. 2003 Aug;27(8 Suppl):47S-51S. doi: 10.1097/01.ALC.0000079449.47468.B0.
4
Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic.
World J Gastroenterol. 2021 Jul 7;27(25):3780-3789. doi: 10.3748/wjg.v27.i25.3780.
5
Changes in Hepatocellular Carcinoma Surveillance and Risk Factors for Noncompletion in the Veterans Health Administration Cohort During the Coronavirus Disease 2019 Pandemic.
Gastroenterology. 2021 May;160(6):2162-2164.e3. doi: 10.1053/j.gastro.2021.01.007. Epub 2021 Jan 9.
6
Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.
World J Gastroenterol. 2008 Jul 21;14(27):4300-8. doi: 10.3748/wjg.14.4300.
7
Hepatocellular carcinoma: status in the era of liver transplantation.
J Okla State Med Assoc. 2009 Dec;102(12):355-61.
8
Screening for hepatocellular carcinoma in high-risk patients: Western versus Eastern virus.
Hepatology. 2003 Jul;38(1):269; author reply 270. doi: 10.1053/jhep.2003.50236.
9
Screening for hepatocellular carcinoma in high-risk populations.
Clin Imaging. 2016 Mar-Apr;40(2):311-4. doi: 10.1016/j.clinimag.2015.11.010. Epub 2015 Nov 23.
10
SARS-CoV-2 infection and liver involvement.
Hepatol Int. 2022 Aug;16(4):755-774. doi: 10.1007/s12072-022-10364-1. Epub 2022 Jun 29.
引用本文的文献
1
Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review.
Explor Target Antitumor Ther. 2023;4(5):1039-1058. doi: 10.37349/etat.2023.00179. Epub 2023 Oct 26.
2
COVID-19 and the Liver: A Complex and Evolving Picture.
Hepat Med. 2023 Nov 7;15:209-220. doi: 10.2147/HMER.S384172. eCollection 2023.
3
Acute Alcohol-Associated Hepatitis in the COVID-19 Pandemic - a Structured Review.
Curr Transplant Rep. 2022;9(4):227-239. doi: 10.1007/s40472-022-00387-w. Epub 2022 Nov 21.
4
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma.
J Clin Med. 2022 Jul 31;11(15):4475. doi: 10.3390/jcm11154475.
5
COVID-19 and liver diseases, what we know so far.
World J Clin Cases. 2022 May 6;10(13):3969-3980. doi: 10.12998/wjcc.v10.i13.3969.
6
Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy.
Curr Oncol. 2022 Feb 24;29(3):1422-1429. doi: 10.3390/curroncol29030119.
Zotero 插件